BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33611093)

  • 1. New germline GATA1 variant in females with anemia and thrombocytopenia.
    Svidnicki MCCM; Filho MAF; Brandão MM; Dos Santos M; de Oliveira Dias R; Tavares RS; Assis-Mendonça GR; Traina F; Saad STO
    Blood Cells Mol Dis; 2021 May; 88():102545. PubMed ID: 33611093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital transfusion-dependent anemia and thrombocytopenia with myelodysplasia due to a recurrent GATA1(G208R) germline mutation.
    Kratz CP; Niemeyer CM; Karow A; Volz-Fleckenstein M; Schmitt-Gräff A; Strahm B
    Leukemia; 2008 Feb; 22(2):432-4. PubMed ID: 17713552
    [No Abstract]   [Full Text] [Related]  

  • 3. A Novel GATA1 Variant in the C-Terminal Zinc Finger Compared with the Platelet Phenotype of Patients with A Likely Pathogenic Variant in the N-Terminal Zinc Finger.
    Bastida JM; Malvestiti S; Boeckelmann D; Palma-Barqueros V; Wolter M; Lozano ML; Glonnegger H; Benito R; Zaninetti C; Sobotta F; Schilling FH; Morgan NV; Freson K; Rivera J; Zieger B
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.
    Åström M; Hahn-Strömberg V; Zetterberg E; Vedin I; Merup M; Palmblad J
    Am J Hematol; 2015 Mar; 90(3):E44-8. PubMed ID: 25421114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [X-linked thrombocytopenia with thalassemia in two families in Sweden. Consider hereditary causes of thrombocytopenia and bone marrow fibrosis].
    Danielsson S; Merup M; Olsson L; Palmblad J; Aström M
    Lakartidningen; 2012 Aug 22-Sep 4; 109(34-35):1474-7. PubMed ID: 22993897
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytopenia: a report of haplo-cord transplantation in twin brothers caused by a novel germline GATA1 mutation and family survey.
    Sun XH; Liu Q; Wu SN; Xu WH; Chen K; Shao JB; Jiang H
    Ann Hematol; 2023 Nov; 102(11):3177-3184. PubMed ID: 37460606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel
    Jurk K; Adenaeuer A; Sollfrank S; Groß K; Häuser F; Czwalinna A; Erkel J; Fritsch N; Marandiuc D; Schaller M; Lackner KJ; Rossmann H; Bergmann F
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.
    Del Vecchio GC; Giordani L; De Santis A; De Mattia D
    Acta Haematol; 2005; 114(2):113-6. PubMed ID: 16103636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation.
    Freson K; Matthijs G; Thys C; Mariën P; Hoylaerts MF; Vermylen J; Van Geet C
    Hum Mol Genet; 2002 Jan; 11(2):147-52. PubMed ID: 11809723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA1 gene variants associated with thrombocytopenia and anemia.
    Freson K; Wijgaerts A; Van Geet C
    Platelets; 2017 Nov; 28(7):731-734. PubMed ID: 28895773
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation.
    Freson K; Devriendt K; Matthijs G; Van Hoof A; De Vos R; Thys C; Minner K; Hoylaerts MF; Vermylen J; Van Geet C
    Blood; 2001 Jul; 98(1):85-92. PubMed ID: 11418466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation.
    Dührsen U; Kratz CP; Flotho C; Lauenstein T; Bommer M; König E; Brittinger G; Heimpel H
    Ann Hematol; 2011 Mar; 90(3):301-6. PubMed ID: 20922527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical and molecular study of a Bedouin family with dysmegakaryopoiesis, mild anemia, and neutropenia cured by bone marrow transplantation.
    Tamary H; Yaniv I; Stein J; Dgany O; Shalev Z; Shechter T; Resnitzky P; Shaft D; Zoldan M; Kornreich L; Levy R; Cohen A; Moser RA; Kapelushnik J; Shalev H
    Eur J Haematol; 2003 Sep; 71(3):196-203. PubMed ID: 12930321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4-independent rescue of the myeloproliferative defect of the Gata1low myelofibrosis mouse model by Aplidin.
    Verrucci M; Pancrazzi A; Aracil M; Martelli F; Guglielmelli P; Zingariello M; Ghinassi B; D'Amore E; Jimeno J; Vannucchi AM; Migliaccio AR
    J Cell Physiol; 2010 Nov; 225(2):490-9. PubMed ID: 20458749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly sensitive detection of GATA1 mutations in patients with myeloid leukemia associated with Down syndrome by combining Sanger and targeted next generation sequencing.
    Terui K; Toki T; Taga T; Iwamoto S; Miyamura T; Hasegawa D; Moritake H; Hama A; Nakashima K; Kanezaki R; Kudo K; Saito AM; Horibe K; Adachi S; Tomizawa D; Ito E
    Genes Chromosomes Cancer; 2020 Mar; 59(3):160-167. PubMed ID: 31606922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Child With Dyserythropoietic Anemia and Megakaryocyte Dysplasia Due to a Novel 5'UTR GATA1s Splice Mutation.
    Zucker J; Temm C; Czader M; Nalepa G
    Pediatr Blood Cancer; 2016 May; 63(5):917-21. PubMed ID: 26713410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis.
    Saultier P; Cabantous S; Puceat M; Peiretti F; Bigot T; Saut N; Bordet JC; Canault M; van Agthoven J; Loosveld M; Payet-Bornet D; Potier D; Falaise C; Bernot D; Morange PE; Alessi MC; Poggi M
    J Thromb Haemost; 2021 Sep; 19(9):2287-2301. PubMed ID: 34060193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.
    Turro E; Greene D; Wijgaerts A; Thys C; Lentaigne C; Bariana TK; Westbury SK; Kelly AM; Selleslag D; Stephens JC; Papadia S; Simeoni I; Penkett CJ; Ashford S; Attwood A; Austin S; Bakchoul T; Collins P; Deevi SV; Favier R; Kostadima M; Lambert MP; Mathias M; Millar CM; Peerlinck K; Perry DJ; Schulman S; Whitehorn D; Wittevrongel C; ; De Maeyer M; Rendon A; Gomez K; Erber WN; Mumford AD; Nurden P; Stirrups K; Bradley JR; Raymond FL; Laffan MA; Van Geet C; Richardson S; Freson K; Ouwehand WH
    Sci Transl Med; 2016 Mar; 8(328):328ra30. PubMed ID: 26936507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.
    Ling T; Crispino JD; Zingariello M; Martelli F; Migliaccio AR
    Expert Rev Hematol; 2018 Mar; 11(3):169-184. PubMed ID: 29400094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA1 in normal and malignant hematopoiesis.
    Crispino JD
    Semin Cell Dev Biol; 2005 Feb; 16(1):137-47. PubMed ID: 15659348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.